SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031612
Filing Date
2024-08-13
Accepted
2024-08-13 16:06:29
Documents
50
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 594330
2 ex10-10.htm EX-10.10 5194
3 ex31-1.htm EX-31.1 11216
4 ex31-2.htm EX-31.2 11243
5 ex32-1.htm EX-32.1 6141
6 ex32-2.htm EX-32.2 6185
7 ex10-10_001.jpg GRAPHIC 833406
8 ex10-10_002.jpg GRAPHIC 811852
9 ex10-10_003.jpg GRAPHIC 858667
10 ex10-10_004.jpg GRAPHIC 277729
11 ex10-10_005.jpg GRAPHIC 111677
  Complete submission text file 0001493152-24-031612.txt   6430738

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE mira-20240630.xsd EX-101.SCH 19619
13 XBRL CALCULATION FILE mira-20240630_cal.xml EX-101.CAL 27955
14 XBRL DEFINITION FILE mira-20240630_def.xml EX-101.DEF 62366
15 XBRL LABEL FILE mira-20240630_lab.xml EX-101.LAB 158662
16 XBRL PRESENTATION FILE mira-20240630_pre.xml EX-101.PRE 121376
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 247634
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: 10-Q | Act: 34 | File No.: 001-41765 | Film No.: 241201409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)